U.s. Food And Drug Administration - Cancer Science

Relevant Publications

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer\'s Disease: Recent Advances and Perspectives.

Issue Release: 2024

Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Issue Release: 2024

Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.

Issue Release: 2024

Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.

Issue Release: 2024

Direct oral anticoagulant use in hospitalized pediatric patients: Insights from nationwide data.

Issue Release: 2024

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL).

Issue Release: 2024

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system.

Issue Release: 2024

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system.

Issue Release: 2024

A one health approach for monitoring antimicrobial resistance: developing a national freshwater pilot effort.

Issue Release: 2024

Efficacy of Prednisone Avoidance in Patients With Liver Transplant Using the U.S. Food and Drug Administration Adverse Event Reporting System.

Issue Release: 2024

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy.

Issue Release: 2024

Mining the Dynamical Properties of Substrate and FAD Binding Pockets of LSD1: Hints for New Inhibitor Design Direction.

Issue Release: 2024

Rescuing a Troubled Tolcapone with PEGylated PLGA Nanoparticles: Design, Characterization, and Hepatotoxicity Evaluation.

Issue Release: 2024

Trends in Varenicline Use for Tobacco Cessation, and Their Implications.

Issue Release: 2024

Artificial Intelligence-Powered Mammography: Navigating the Landscape of Deep Learning for Breast Cancer Detection.

Issue Release: 2024

Fair Balance of Prescription Drug Information on Legitimate and Illegitimate Online Pharmacy Websites.

Issue Release: 2024

A Pharmacovigilance Study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration adverse event reporting system (FAERS) database.

Issue Release: 2024

Plant-based zinc nanoflowers assisted molecularly imprinted polymer for the design of an electrochemical sensor for selective determination of abrocitinib.

Issue Release: 2024

Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial.

Issue Release: 2024

Signs and symptoms: Adverse events associated with a sterilization device.

Issue Release: 2024

How Does Autoclaving Benefit Cancer Treatment Facilities?

What is an Endo Stapler?

How Do Environmental Exposures Affect Future Generations?

What is OpenCravat?

What is Hope Lodge?

What is Telepharmacy?

What Types of Workshops and Seminars Are Available?

Which Cancers Are Most Prone to False Negatives?

How to Prepare for a LEEP Procedure?

What Role do Paraneoplastic Syndromes Play?

U.s. Food And Drug Administration - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics